Asieris Appoints Dr. Linda Wu as Chief Development Officer

SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Asieris Appoints Dr. Linda Wu as Chief Development Officer

Related Keywords

China ,United States ,Shanghai ,Chinese ,Kevin Pan ,Linda Wu ,Bayer Pharmaceuticals ,Head Of Clinical Development Oncology ,University Of Southern California ,Development Team Leader At Janssen ,Chinese Academy Of Sciences ,Asieris Pharmaceuticals ,Shanghai Medical College Of Fudan University ,Janssen Pharmaceuticals ,Shanghai Institute Of Materia Medica ,Johnson ,Us Medical Affairs ,Chief Development Officer ,Group Medical Director ,Senior Director ,Clinical Development ,Compound Development Team Leader ,Molecular Biology ,Southern California ,Cancer Pharmacology ,Shanghai Institute ,Materia Medica ,Chinese Academy ,Shanghai Medical College ,Asieris Appoints Dr Linda Wu As Chief Development Officer ,